Skip to Accessibility Menu Skip to Login Skip to Content Skip to Footer

Have you heard about these latest FDA-approved MG treatments?

Jodi Enders

Have you heard of these latest FDA-approved MG treatments:

"Rituximab (Rituxan®) can treat refractory MG with anti-muscle-specific kinase (MuSK) antibodies.

Efgartigimod alfa and hyaluronidase-qvfc (Vyvgart® Hytrulo) can treat people with generalized MG (gMG) with anti-AChR antibodies.

Rozanolixizumab-noli (Rystiggo®) can treat people with generalized MG (gMG) with anti-AChR or anti-MuSK antibodies.

Zilucoplan (Zilbrysq®) is used to treat generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive"
(https://myasthenia-gravis.com/treatment)?

Have you had a chance to talk with your doctor about any of these new treatments? Are you hopeful about the future of MG research and treatment with all these new options becoming available?
Jodi, Team Member